Literature DB >> 30733314

First Human Imaging Studies with the EXPLORER Total-Body PET Scanner.

Ramsey D Badawi1,2, Hongcheng Shi3, Pengcheng Hu3, Shuguang Chen3, Tianyi Xu4, Patricia M Price5, Yu Ding4, Benjamin A Spencer6, Lorenzo Nardo6, Weiping Liu4, Jun Bao4, Terry Jones6, Hongdi Li4, Simon R Cherry6,2.   

Abstract

Within the EXPLORER Consortium, the construction of the world's first total-body PET/CT scanner has recently been completed. The 194-cm axial field of view of the EXPLORER PET/CT scanner is sufficient to cover, for the first time, the entire human adult body in a single acquisition in more than 99% of the population and allows total-body pharmacokinetic studies with frame durations as short as 1 s. The large increase in sensitivity arising from total-body coverage as well as increased solid angle for detection at any point within the body allows whole-body 18F-FDG PET studies to be acquired with unprecedented count density, improving the signal-to-noise ratio of the resulting images. Alternatively, the sensitivity gain can be used to acquire diagnostic PET images with very small amounts of activity in the field of view (25 MBq, 0.7 mCi or less), with very short acquisition times (∼1 min or less) or at later time points after the tracer's administration. We report here on the first human imaging studies on the EXPLORER scanner using a range of different protocols that provide initial evidence in support of these claims. These case studies provide the foundation for future carefully controlled trials to quantitatively evaluate the improvements possible through total-body PET imaging.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  EXPLORER; FDG; PET; PET/CT; instrumentation; total-body PET

Mesh:

Year:  2019        PMID: 30733314      PMCID: PMC6424228          DOI: 10.2967/jnumed.119.226498

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.

Authors:  Gunnar Brix; Ursula Lechel; Gerhard Glatting; Sibylle I Ziegler; Wolfgang Münzing; Stefan P Müller; Thomas Beyer
Journal:  J Nucl Med       Date:  2005-04       Impact factor: 10.057

Review 2.  Total-body imaging: Transforming the role of positron emission tomography.

Authors:  Simon R Cherry; Ramsey D Badawi; Joel S Karp; William W Moses; Pat Price; Terry Jones
Journal:  Sci Transl Med       Date:  2017-03-15       Impact factor: 17.956

Review 3.  Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care.

Authors:  Simon R Cherry; Terry Jones; Joel S Karp; Jinyi Qi; William W Moses; Ramsey D Badawi
Journal:  J Nucl Med       Date:  2017-09-21       Impact factor: 10.057

4.  Optimal whole-body PET scanner configurations for different volumes of LSO scintillator: a simulation study.

Authors:  Jonathan K Poon; Magnus L Dahlbom; William W Moses; Karthik Balakrishnan; Wenli Wang; Simon R Cherry; Ramsey D Badawi
Journal:  Phys Med Biol       Date:  2012-06-07       Impact factor: 3.609

5.  Mini EXPLORER II: a prototype high-sensitivity PET/CT scanner for companion animal whole body and human brain scanning.

Authors:  Yang Lv; Xinyu Lv; Weiping Liu; Martin S Judenhofer; Allison Zwingenberger; Erik Wisner; Eric Berg; Sarah McKenney; Edwin Leung; Benjamin A Spencer; Simon R Cherry; Ramsey D Badawi
Journal:  Phys Med Biol       Date:  2019-03-21       Impact factor: 3.609

  5 in total
  116 in total

1.  The Potential of PET in the Management of Peripheral Arterial Disease.

Authors:  Sanjay Divakaran; Piotr S Sobieszczyk; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2019-08-14

Review 2.  Atherosclerosis Immunoimaging by Positron Emission Tomography.

Authors:  Carlos Pérez-Medina; Zahi A Fayad; Willem J M Mulder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-06       Impact factor: 8.311

3.  Ultra-short time imaging of total-body PET/CT for cancer pain-induced untenable body position.

Authors:  Yongjiang Li; Wenbiao Zhang; Hu Zhang; Chao Zhou; Liangshun Xiong; Xu Zhang; Wei Fan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-08       Impact factor: 9.236

4.  Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT.

Authors:  Yu-Mo Zhao; Ying-He Li; Tao Chen; Wei-Guang Zhang; Lin-Hao Wang; Jiatai Feng; Chenwei Li; Xu Zhang; Wei Fan; Ying-Ying Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-18       Impact factor: 9.236

5.  Dynamic PET imaging with ultra-low-activity of 18F-FDG: unleashing the potential of total-body PET.

Authors:  Xiaoli Lan; Kevin Fan; Ke Li; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-30       Impact factor: 9.236

6.  The image quality, lesion detectability, and acquisition time of 18F-FDG total-body PET/CT in oncological patients.

Authors:  Yi-Qiu Zhang; Peng-Cheng Hu; Run-Ze Wu; Yu-Shen Gu; Shu-Guang Chen; Hao-Jun Yu; Xiang-Qing Wang; Jun Song; Hong-Cheng Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-18       Impact factor: 9.236

7.  Total Body PET: Why, How, What for?

Authors:  Suleman Surti; Austin R Pantel; Joel S Karp
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2020-04-03

8.  Assessment of femoral neck bone metabolism using 18F-sodium fluoride PET/CT imaging.

Authors:  Sylvia Rhodes; Alexandra Batzdorf; Olivia Sorci; Matthew Peng; Amanda Jankelovits; Julia Hornyak; Jongyun An; Peter B Noël; Poul F Høilund-Carlsen; Abass Alavi; Chamith S Rajapakse
Journal:  Bone       Date:  2020-04-08       Impact factor: 4.398

9.  Structural and practical identifiability of dual-input kinetic modeling in dynamic PET of liver inflammation.

Authors:  Yang Zuo; Souvik Sarkar; Michael T Corwin; Kristin Olson; Ramsey D Badawi; Guobao Wang
Journal:  Phys Med Biol       Date:  2019-09-05       Impact factor: 3.609

10.  Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection.

Authors:  Eric Berg; Herman Gill; Jan Marik; Annie Ogasawara; Simon Williams; Guus van Dongen; Daniëlle Vugts; Simon R Cherry; Alice F Tarantal
Journal:  J Nucl Med       Date:  2019-09-27       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.